Study of Skin Tumors in Tuberous Sclerosis

Status Recruiting

Clinical Trial Summary

Tuberous sclerosis is a rare, hereditary disease in which patients develop multiple tumors. Although not cancerous, the tumors can affect various organs, including the heart, lungs, kidneys, skin, and central nervous system, with serious medical consequences. The severity of disease varies greatly among patients, from barely detectable to fatal. This study will investigate what causes skin tumors to develop in patients with this disease. Patients with tuberous sclerosis 18 years and older may enroll in this study. Participants will undergo a medical history and thorough skin examination by a dermatologist. Those with skin tumors will be asked to undergo biopsy (tissue removal) of up to eight lesions, under a local anesthetic, for research purposes. The biopsies will all be done the same day. The tissue samples will be used for: examination of genetic changes, measurement of certain proteins and other substances, and growing in culture to study the genetics of tuberous sclerosis.

Clinical Trial Description

Patients with tuberous sclerosis develop benign cutaneous tumors that are typically multiple in number and location. These tumors include facial angiofibromas, forehead plaques, shagreen patches, periungual fibromas, and gingival fibromas. The tumors are permanent, slow growing, and often disfiguring. The purpose of this study is to elucidate the molecular basis for these tumors. Specifically, we plan to identify the genetically altered cells in these hamartomatous lesions, and to quantify factors (e.g. cytokines) produced by these cells which induce the growth of these tumors. To accomplish this, we plan to obtain samples of these cutaneous tumors, to test tumor DNA for loss of heterozygosity, and to measure RNA and protein expression levels. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00001975
Study type	Observational
Source	National Institutes of Health Clinical Center (CC)
Contact	Tatyana Worthy, R.N.
Phone	(301) 827-1376
Email	worthyt@mail.nih.gov
Status	Recruiting
Phase
Start date	January 26, 2000

View Details

See also
Status	Clinical Trial	Phase
Enrolling by invitation	`NCT06139172` - Promoting Prosocial Behavior in Syndromic Intellectual and Developmental Disabilities	N/A
Recruiting	`NCT00001532` - Role of Genetic Factors in the Development of Lung Disease
Completed	`NCT00552955` - Effect of Fasting on the Size of Abdominal Lymphatic Tumors in Women
Recruiting	`NCT03422367` - JASPER Early Intervention for Tuberous Sclerosis	N/A
Not yet recruiting	`NCT06081348` - Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental Disorders	Phase 2
Unknown status	`NCT00490789` - Trial of Efficacy and Safety of Sirolimus in Tuberous Sclerosis and LAM	Phase 2
Recruiting	`NCT04463316` - GROWing Up With Rare GENEtic Syndromes
Recruiting	`NCT06065852` - National Registry of Rare Kidney Diseases
Enrolling by invitation	`NCT03836300` - Parent-Infant Inter(X)Action Intervention (PIXI)	N/A
Completed	`NCT02104011` - Treatment of Renal Angiomyolipomas in Tuberous Sclerosis by Beta-blockers	Phase 2
Recruiting	`NCT02461459` - Autism Spectrum Disorder (ASD) and Intellectual Disability (ID) Determinants in Tuberous Sclerosis Complex (TSC)
Completed	`NCT01526356` - Topical Rapamycin to Erase Angiofibromas in TSC	Phase 2
Withdrawn	`NCT03254680` - Turmeric as Treatment in Epilepsy	N/A
Terminated	`NCT01092208` - Studies of Autistic Patients: Gene Networks and Clinical Subtypes
Active, not recruiting	`NCT01954693` - A Study of Everolimus in the Treatment of Neurocognitive Problems in Tuberous Sclerosis	Phase 2
Completed	`NCT03826628` - Dose-Ranging Efficacy and Safety Study of Topical Rapamycin Cream for Facial Angiofibroma Associated With Tuberous Sclerosis Complex	Phase 2/Phase 3
Completed	`NCT00989742` - Doxycycline In Lymphangioleiomyomatosis (LAM)	Phase 4
Recruiting	`NCT05286632` - KidneYou - Innovative Digital Therapy	N/A
Withdrawn	`NCT04344626` - Use of a Tonometer to Identify Epileptogenic Lesions During Pediatric Epilepsy Surgery	N/A
Recruiting	`NCT05199402` - Clinical Trial Data Set Re-use With Statistical Methodologies Tailored for Clinical Trials in Rare Diseases